Determination of the Efficacy and Safety of the Seasonal Influenza Vaccine Among Patients Suffering From Sarcoidosis.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Acronyms SARCOVAC
- 21 Apr 2015 Biomarkers information updated
- 02 Aug 2013 Planned End Date changed from 1 Dec 2013 to 1 Mar 2014 as reported by ClinicalTrials.gov.
- 02 Aug 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.